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Aims of this commentary is to report the most recent views about epidemiology, diagnostic procedures, malignancy
risk factors and clinical management of thyroid nodules in children. On the basis of our personal experiences and
recent literature evidences, we conclude that: a) if nodule is accompanied by lymphadenopathy and/or other alert
findings, fine-needle aspiration biopsy (FNAB) should be recommended; b) if no lymphadenopathy and no other clinical
and ultrasonographic alert signs are observed, work-up can progress to FNAB only if nodule persists or grows over time,
even under levo-thyroxine therapy.
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Thyroid cancer, i.e. the fifth leading cancer in women, the
most common endocrine malignancy and also the fastest
rising cancer in both genders [1,2], usually presents as a
thyroid nodule. Although nodules in childhood are rare,
they are not infrequently malignant (up to 25% of cases)
and therefore require a careful evaluation and an aggres-
sive diagnostic approach.
Due to the above considerations, we believe that this
issue deserves a specific commentary, aiming to report
the most recent views about epidemiology, diagnostic
procedures, malignancy risk factors and clinical manage-
ment of nodular disease in childhood.Epidemiology
Nodule prevalence in adults has been estimate to range
from 2 to 6% by palpation, from 19 to 35% by ultrasonog-
raphy (US) and from 8 to 65% in postmortem examina-
tions [3]. Although the epidemiological studies in pediatric
age are very scanty, nevertheless US prevalences in child-
hood may be estimated to range from 0.2 to 5.1% [4,5].
However, the cancer risk of a thyroid nodule is signifi-
cantly greater in children than in adults (22 vs 14%) [6].* Correspondence: filippo.deluca@unime.it
Department of Pediatrics, University of Messina, Via Consolare Valeria, 98124
Messina, Italy
© 2014 De Luca et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Even rates of cancer metastasis and extrathyroidal exten-
sion have been found to be much higher in children [7,8].
Also sex distribution seems to change with age. In fact,
whereas in adults women outnumber men 4:1, in chil-
dren below 15 the ratio of girls to boys is 1.5:1 and in
patients aged 15–20 the female: male ratio is 3:1 [9].
A significant risk factor for the occurrence of thyroid
nodular disease is the association with Hashimoto’s thy-
roiditis (HT), as suggested by a recent study demonstrat-
ing an increase prevalence of nodules (31.5%) in children
with HT [10].US and clinical risk factors for thyroid cancer
Excluding malignancy is the diagnostic goal of thyroid
nodule evaluation in both adults and children [11].
In children a nodule should be reviewed with suspicion,
due to the relevant relative risk of malignancy in pediatric
age [4]. In particular, it has to be considered, on the basis
of epidemiological data, that males and very young chil-
dren (<10 years) are the patients with the highest risk of
cancer [4].
Cancer rate is significantly associated with method of
nodule discovery and the patients with ultrasonographic
(US) incidentalomas have the lowest malignancy rate (4%),
whereas those with clinical diagnosis have a much higher
cancer prevalence (30%) [12].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Anamnestic, clinical, laboratory and
ultrasonographic (US) risk factors for malignancy in the
diagnostic approach to children’ thyroid nodules
Anamnestic data Laboratory data
– Family history for thyroid cancer – Increased thyrotropin levels
– Previous cancer – High calcitonin levels
– History of irradiation exposure US data
Clinical data – Nodule hypoechogenicity
– Lymphoadenopathy – Nodule microcalcifications
– Signs of compression of
adjacent structures
– Nodule undefined margins
– Nodule growth under
levothyroxine therapy
– Increased intranodular vascular flow
– Specific lymph node alterations
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tween benign and malignant nodules, it does provide
very useful information in selecting the children to be
evaluated by fine-needle aspiration biopsy (FNAB).
Among US parameters, hypoechogenicity, microcalcifi-
cations, specific lymph node alterations and increased
intranodular vascular flow are all findings indicating a
high suspicion for cancer [13].
The lymph node US alterations which have been found
to correlate with an increased risk of malignancy are: ir-
regular margins, heterogeneous echoic pattern, calcifica-
tions and irregular vascularity throughout the lymph node
instead of the normal central hilar vessels at Doppler im-
aging [14].
The anamnestic and clinical findings that are consid-
ered to have some predictive value for malignancy are:
family history for thyroid cancer, previous oncohematolo-
gical disorders, history of irradiation exposure, presence of
palpable lymph nodes and symptoms attributable to com-
pression of adjacent structures (discomfort, dysfagia, dys-
phonia, hoarseness, breathing obstruction) [14]. From a
clinical point of view, another aspect which should be con-
sidered in the evaluation of nodule prognosis is whether
isolated and multiple nodules have the same risk of malig-
nancy. Consistent with other reports [15], our results sug-
gest that cancer may also be present in multinodular
thyroid disease, although the majority of malignant nodules
are isolated [14].
Finally, spontaneous growth of nodules and effectiveness
of levo-thyroxine (L-T4) therapy in shrinking their dimen-
sions may give further information in the evaluation
of nodule prognosis. In fact, a significant size reduction
(>50%) is known to occur in 30% of children with benign
nodules, whereas in untreated subjects both palpable nod-
ules and symptoms increase [16].
Other diagnostic investigations
Among the conventional diagnostic investigations, FNAB
is, even in childhood and adolescence, the one that offers
the best sensitivity (95%), specificity (86%), and accuracy
(90%) rates in detecting malignancy [17]. These inferences
have been more recently confirmed [14,18,19] and, there-
fore, it can be argued that FNAB plays a crucial role in the
management of children’ thyroid nodules, since it allows a
selection of patients to undergo surgery [14].
Measuring thyrotropin (TSH) and free thyroxine levels
at nodule detection is mandatory to assess thyroid func-
tion and establish the further work-up. Patients with
hyperthyroidism are likely to be affected by toxic aden-
omas and, therefore, scintiscan is indicated. However,
the large majority of children with either benign or ma-
lignant nodules are euthyroid and only a small fraction
of thyroid cancers can present with hot/warm scintiscan
uptake [14].Blood calcitonin level measurement may be very useful
at nodule detection, because this test is crucial for an
early diagnosis of medullary carcinoma.
Among thyroid function tests, TSH measurement seems
to be possibly used also for a prognostic purpose, since
the highest TSH quintiles have been just recently demon-
strated to be associated with an increased risk of malig-
nancy [20].
Relative histotypes of pediatric thyroid nodules
According to the results of a recent paper of our multicen-
ter study group, malignant histotypes were found in 30%
of children with nodular disease [14]. The most frequent
malignant histotype was papillary carcinoma (22.2%),
followed by follicular carcinoma (4.7%) and medullary car-
cinoma (3.2%), whereas the most frequent benign histo-
type was goitrous nodule (53.4%) followed by follicular
adenoma (12.7%), Hurthle cell adenoma (3.2%) and benign
teratoma (1.6%). All the patients with a malignant histo-
type had exhibited at cytologic evaluation an either malig-
nant or suspicious aspect, with no false negatives. Based
on these results, FNAB had 100% sensitivity, 83.3% specifi-
city and 89.1% diagnostic accuracy [14].
Pre-surgical management of children’ thyroid nodules
Even though the long-term prognosis of children with thy-
roid malignancy may be favourable, even in the cases with
extrathyroidal extension and metastasis [7,8], early detec-
tion improves outcome [15]. Moreover, many children
with thyroid nodules undergo extensive and costly work-
up before being referred to surgeons [21]. Due to these
reasons it is mandatory to identify the minimal work-up
preceding surgery.
On the basis of our personal experiences [10,14,16,17,20]
and recent literature evidences [6,12,13,21], we suggest that:
a) if a palpable nodule in a euthyroid child is accompanied
by lymphadenopathy or signs of compression and/or other
alert findings (Table 1), the suspicion of malignancy may be
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adenopathy and no other clinical and US alert signs are ob-
served, work-up can progress to FNAB only if nodule
persists or grows over time, even under L-T4 therapy.
Follow-up of children with benign thyroid nodules
on FNAB
The initial finding of a benign lesion on FNAB does not ex-
clude per se the presence of a malignancy, since cytological
evaluation has a sensitivity which ranges from 75 to 95% in
the different studies [14,17-19,22]. Therefore, it advisable
that pediatric endocrinologists continue to follow over time
their young patients with persisting nodules, even those
with previously documented benign lesions on FNAB.
Moreover, it has to be considered that persisting palpable/
visible nodules proven to be benign by FNAB may still be
causing long-lasting worries for the children’s families.
Follow-up of young patients with initially detected be-
nign nodules should take into consideration all the
above described clinical and US predictive factors of ma-
lignancy. In particular, the factors that have been re-
ported to be most frequently associated with cancer risk
are: family history of thyroid cancer, hypoechoic lesions
and palpable lymph nodes [23]. In children with persist-
ing nodules, the presence of any of these risk factors
should heighten suspicion for malignancy, even in the
setting of a benign FNAB [23].
It is sometimes discussed, among the pediatricians,
whether the long-lasting anxieties of children’s parents
for the persistence of a nodule would be an indication
for surgery. According to other Authors, patients with a
benign FNAB and no clinical and US criteria for malig-
nancy may not need to be referred to the surgeon [23].
In our opinion, such inference might be largely sub-
scribed to.
Conclusions
a) thyroid nodules in childhood are not infrequently ma-
lignant and require a well-established diagnostic ap-
proach; b) the children to be evaluated by FNAB should
be selected by analysis of clinical and US risk factors;
c) lymphadenopathy and compression signs are the most
specific clinical signs; d) nodular microcalcifications and
specific lymph node alterations are the most reliable US
risk factors; e) in the cases with either positive or suspi-
cious cytological evaluation after FNAB, surgery has to
be strongly recommended; f ) in the patients with benign
thyroid nodules on FNAB clinical follow-up with serial
physical and US examinations is recommended; g) sur-
gery might be taken into consideration even in the cases
with previously documented benign lesion on FNAB,
when the strongest clinical and US risk factors are
present; h) the most frequent malignant histotype is pap-
illary carcinoma.Abbreviations
FNAB: Fine-needle aspiration biopsy; HT: Hashimoto’s thyroiditis;
L-T4: levothyroxine; TSH: Thyrotropin; US: Ultrasonography.
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